Guggenheim raises Roivant Sciences price target to $46 from $42
Guggenheim raised its price target for Roivant Sciences to $46.00 from $42.00 and maintained a Buy rating, per Benzinga.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.